Last reviewed · How we verify
NCT06815913
To Develop and Introduce Into Polyclinic Practice a Register of Patients with Experience of Myocardial Infarction and Acute Cerebrovascular Disease
trial in Myocardial Infarction (MI) in 2,000 participants. Participants enrolled and being followed up; not accepting new ones.
31 December 2025
Quick facts
| Lead sponsor | State Institution "Republican Scientific and Practical Center" Cardiology, Belarus |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 2,000 |
| Start date | 1 March 2024 |
| Primary completion | 31 December 2025 |
| Estimated completion | 1 June 2026 |
| Sites | 1 location across Belarus |
Conditions studied
- Myocardial Infarction (MI) — all drugs for Myocardial Infarction (MI) →
- Acute Cardiovascular Disease — all drugs for Acute Cardiovascular Disease →
Sponsor
State Institution "Republican Scientific and Practical Center" Cardiology, Belarus — full company profile →
Who can join
18 and older, any sex, with Myocardial Infarction (MI) or Acute Cardiovascular Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a retrospective observational study using the methodology of creating medical registries. The expected number of patients included in the registry is about 2000 patients with myocardial infarction and/or ACVD of any duration and concomitant non-cardiac diseases of therapeutic profile in pilot healthcare organizations for any reason during 2019-2022 based on the source medical records data.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06815913
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myocardial Infarction (MI)
Currently open trials in the same condition.
- NCT07052799 — Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonoscopy and/o · Phase 3 · recruiting
- NCT07320625 — Efficacy of Montelukast on STEMl Patients · Phase 3 · recruiting
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07137936 — Cardiac Magnetic Resonance - PROgnostic HEart Scar for Sudden Cardiac Death Prediction StudY · recruiting
- NCT07243769 — A Pilot Randomized Controlled Trial Comparing Core Exercise, Aerobic Exercise, and Combined Exercise in Patients Undergo · NA · recruiting
Other State Institution "Republican Scientific and Practical Center" Cardiology, Belarus trials
Trials by the same sponsor.
- NCT07159698 — Clinical Profile of a Patient After MI and ACVA Based on Outpatient Register Data · enrolling by invitation
- NCT05800821 — Prediction of Cerebral Hyperperfusion Syndrome After Carotid Revascularization Using Deep Learning · recruiting
- NCT04588935 — Prevention of Cardiovascular Diseases Caused by Complex Treatment of Patients With Primary Operated Breast Cancer · Phase 2 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06815913 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by State Institution "Republican Scientific and Practical Center" Cardiology, Belarus
- Last refreshed: 10 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06815913.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing